Moderna stock surged on Tuesday amid what has been a lively past few days for the pharmaceutical industry. The tumultuous ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

Kong told MedPage Today that previous research has found that vaccine uptake and completion varies by race and ethnicity, ...

U.S. stocks experienced a mixed session on Tuesday as investors reacted to President Trump's latest tariff threats, creating ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

The top shareholders of Moderna are Stéphane Bancel, Noubar B. Afeyan, Stephen Hoge, Baillie Gifford & Co., Vanguard Group Inc., and BlackRock Inc.

Get the latest Moderna, Inc. (MRNA) stock news and headlines to help you in your trading and investing decisions.